Lexicon Pharmaceuticals (LXRX) Capital Expenditures (QoQ) (2010 - 2024)
Lexicon Pharmaceuticals (LXRX) Capital Expenditures (QoQ) (2010 - 2024) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Lexicon Pharmaceuticals |
804.48 Mn |
633.82 Mn |
20.99 Mn |
| Date | Value |
|---|
| Dec 31, 2024 |
54.40% |
| Sep 30, 2024 |
22.80% |
| Sep 30, 2023 |
-40.29% |
| Jun 30, 2023 |
-43.95% |
| Mar 31, 2023 |
-80.10% |
| Dec 31, 2022 |
31,050.00% |
| Mar 31, 2022 |
230.43% |
| Dec 31, 2021 |
-89.20% |
| Sep 30, 2021 |
-77.51% |
| Jun 30, 2021 |
2,392.11% |
| Mar 31, 2021 |
-29.63% |
| Dec 31, 2020 |
63.64% |
| Mar 31, 2019 |
89.19% |
| Dec 31, 2018 |
1,133.33% |
| Sep 30, 2018 |
-80.00% |
| Jun 30, 2018 |
-62.50% |
| Mar 31, 2018 |
900.00% |
| Dec 31, 2017 |
-93.44% |
| Sep 30, 2017 |
-14.08% |
| Jun 30, 2017 |
-22.83% |
